skip to content

Roche's event on key data presented at the MDA Virtual Clinical & Scientific Conference 2021

Roche has hosted a virtual event on Friday, 19th March 2021

Agenda:
Phase II/III SUNFISH part 2: 24-month efficacy and safety of risdiplam in patients with Type 2 or non-ambulant Type 3 spinal muscular atrophyPaulo Fontoura, M.D. Ph.D., Global Head Neuroscience and Rare Diseases Clinical Development
Roche Neuroscience and Rare Disease franchise updateSimona Skerjanec, Therapeutic Area Head Neuroscience and Rare Diseases, Global Product Strategy
Q&AKarl Mahler, Head of Investor Relations and Roche Group Planning

Webinar Replay

Investors

Past IR Events
View more Events

Downloads

Presentation

PDF

Related links

Roche’s Annual Report 2020Investors

How medicines are making an impact in the lives of patients

GovernanceAbout Roche

Our corporate governance principles focus on sustainable value creation and prescribe a culture that recognises standards of good corporate governance and policy of transparent communication.

Product Development PipelineSolutions

Discover our pipeline of Pharmaceutical and Diagnostics developments

Frequently asked questionsInvestors

We answer the Roche investors-related most frequently asked questions